Skip to main content

Search UC San Diego Today

Keyword is required

Your search for “antivira drugs” returned 49 results

Pharming the Microbiome

The gut microbiome plays a critical but poorly understood role in how drugs work or don’t work in the body. It also presents therapeutic possibilities unto itself.

$55M NIH Grant Advances Clinical and Translational Research at UC San Diego

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.

Statins Reduce COVID-19 Severity, Likely by Removing Cholesterol That Virus Uses to Infect

Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellular mechanism that helps explain why.

Scripps Professor Receives Research Achievement Award

Scripps Institution of Oceanography at UC San Diego Distinguished Professor William Gerwick received the American Society of Pharmacognosy’s Norman R. Farnsworth Research Achievement Award for his outstanding contributions to natural products research. Gerwick will accept the award during the Society’s annual meeting in July at the 2016 Joint Natural Products Conference in Copenhagen.

New Research Provides Clues on Optimizing Cell Defenses When Viruses Attack

UC San Diego scientists are providing new clues on how cells defend themselves from attack from viruses. The new study advance’s science’s understanding of interferons— proteins that help combat viruses like SARS-CoV-2—with possible implications for new clinical treatments.

UC San Diego VC Partner Osage Invests in Antiva

Antiva Biosciences, a spinout of UC San Diego, closed a $22M Series C financing in March. Antiva is a clinical stage biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by Human Papilloma Virus (HPV) infection. Osage University Partners, a venture capital firm partnered with UC San…

Organoids Reveal How SARS-CoV-2 Damages Brain Cells — and a Potential Treatment

Using human brain organoids, an international team of researchers has shown how the SARS-CoV-2 virus that causes COVID-19 infects cortical neurons and specifically destroys their synapses — the connections between brain cells that allow them to communicate with each other.

Experimental Therapy for Parasitic Heart Disease May Also Help Stop COVID-19

UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.

UC San Diego Breaks Ground on Revitalization of Hillcrest Campus

A celebratory groundbreaking event marks the beginning of a comprehensive revitalization project of UC San Diego’s Hillcrest campus, which upon completion will feature state-of-the-art facilities, expanded patient care services and technologies and other community amenities to promote wellbeing.

Mapping Mutation ‘Hotspots’ in Cancer Reveals New Drivers and Biomarkers

UC San Diego researchers have identified a previously unrecognized key player in cancer evolution: clusters of mutations occurring at certain regions of the genome. These mutation clusters contribute to the progression of about 10% of human cancers and can be used to predict patient survival.